Does Boxing Really Help Parkinson's Balance? What the Research Actually Shows

Two independent reviews looked for a balance benefit from boxing in Parkinson's. Neither found one. Here's what actually does — and why that doesn't mean boxing is a waste of anyone's time.

Boxing-for-Parkinson's programs have grown fast across the country, ours included in spirit — Rochester has several options built around the idea that boxing sharpens balance and slows the disease's effect on movement. It's a compelling story. It's also gotten ahead of what the research actually shows.

What two reviews actually found

In 2025, a research team pooled every peer-reviewed study they could find on boxing programs for older adults with Parkinson's — eight studies, 100 participants — and looked specifically at balance, cardiorespiratory fitness, motor function, and quality of life [1]. The result: no statistically significant effect on any of them, including balance measured by the Activities-specific Balance Confidence Scale and the Timed Up-and-Go test [1].

A second, independent team ran the same question with a wider net — 13 studies — the following year and reached the same conclusion: no significant effect on functional mobility, balance, motor symptoms, gait, or cardiorespiratory fitness [2]. Two separate groups, two separate searches of the literature, the same answer. That's not one disappointing study; that's the honest state of the evidence right now.

Neither review found boxing harmful — nobody got worse. The finding is narrower and more useful than that: boxing hasn't been shown, in controlled research, to move the specific needles — balance, falls risk, quality of life — that it's often marketed as moving.

What does have real evidence behind it

The idea that boxing might help isn't baseless — it usually comes from a real, different intervention called LSVT-BIG, built around large, deliberate movements to counter the smaller, shrinking motions Parkinson's tends to cause. A systematic review of that specific program — 16 structured sessions with a certified instructor over four weeks — found a real improvement in motor function compared to standard physiotherapy or a shorter version of the same program [3]. It's a small evidence base (three trials, 84 people) and the researchers call it moderate-quality, preliminary evidence — not proof beyond doubt. But it's a real, measured effect, in a way boxing's research currently is not.

The difference matters: LSVT-BIG is a specific, certified clinical protocol built and dosed around amplitude of movement. A boxing class shares some of that big-movement quality, but "shares a quality with" isn't the same as "is." A 2014 Cochrane review that tried to rank physiotherapy approaches against each other in Parkinson's — general exercise, treadmill training, cueing, dance, martial arts — found the studies too small and too varied to say which technique works best for which outcome [4]. That's the honest shape of this whole field: movement broadly helps in Parkinson's, but the evidence for which specific approach helps which specific outcome is still catching up — and for boxing and balance specifically, it hasn't caught up yet.

What this means for you

If you're choosing a program specifically to protect your balance, the evidence points toward amplitude-focused, individually dosed programs like LSVT-BIG rather than general boxing classes — ask any program, including ours, what evidence stands behind what they're recommending for your specific goal.

If you're already boxing, or thinking about starting, that's still a legitimate choice — for cardiovascular fitness, for the structure and social contact of a regular class, for the plain fact that people who enjoy a workout do it more consistently than people who don't. Just choose it for those honest reasons, not because it's been proven to protect your balance, which right now it hasn't.

At RSF, boxing classes are general conditioning, open to anyone — not marketed as a Parkinson's-specific treatment. Our Parkinson's program focuses on what the evidence currently supports for that goal.

Eating to support this

Nutrition in Parkinson's has one wrinkle most general healthy-eating advice misses entirely: dietary protein can interfere with how well levodopa — the core medication most people with PD take — gets absorbed. Amino acids from protein compete with levodopa for the same transport system into the bloodstream and across the blood-brain barrier, and for people experiencing motor fluctuations (medication that seems to "wear off" unpredictably), that competition can matter [5].

The two approaches clinicians use are a low-protein diet or, more commonly, a protein-redistribution diet — keeping meals earlier in the day lighter on protein and moving most of the day's protein to the evening, after the medication doses that matter most for daytime function. A 2023 review of this research is honest about its limits: the evidence base is thin, there's no single agreed standard for how to do it, and done carelessly it risks unintended weight loss or dyskinesia — so this genuinely isn't a change to make on your own from a blog post [5].

What it does mean: if you or someone you're caring for is on levodopa and noticing your medication feels less predictable at certain times of day, protein timing is a real, legitimate thing to bring up with your neurologist or a registered dietitian who works with movement disorders — not a guess, an actual documented interaction worth asking about by name.

Talk to your doctor or neurologist

Balance and fall risk in Parkinson's are worth a direct conversation with your neurologist or a physical therapist experienced with the disease — they can point you toward an assessment and a program matched to where you are, rather than a general recommendation. This is especially true if you've had a recent fall or a near-fall; that's a conversation to have this week, not eventually.

Sources: [1] Hernandez-Martinez et al., Frontiers in Public Health 2025, pubmed.ncbi.nlm.nih.gov/40547458 · [2] González-Devesa et al., Revista de Neurología 2024, pubmed.ncbi.nlm.nih.gov/39833025 · [3] McDonnell et al., Clinical Rehabilitation 2018, pubmed.ncbi.nlm.nih.gov/28980476 · [4] Tomlinson et al., Cochrane Database of Systematic Reviews 2014, pubmed.ncbi.nlm.nih.gov/24936965 · [5] Rusch et al., npj Parkinson's Disease 2023, pubmed.ncbi.nlm.nih.gov/37355689